Takeda Pharmaceutical
300 hedge funds and large institutions have $1.38B invested in Takeda Pharmaceutical in 2023 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 109 increasing their positions, 67 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 281 → 300 (+19)
1.2% more ownership
Funds ownership: 4.3% → 5.5% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
300
Holding in Top 10
3
Calls
$37.8M
Puts
$6.12M
Top Buyers
| 1 | +$180M | |
| 2 | +$28M | |
| 3 | +$26.4M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$14.7M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$9.07M |
Top Sellers
| 1 | -$46.9M | |
| 2 | -$12.7M | |
| 3 | -$4.71M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.18M |
| 5 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$3.31M |